Related Experiment Video
Updated: May 7, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Therapeutic Drug Monitoring Versus Fixed-Interval Dosing of Dalbavancin in Implant-Associated Spinal Infections:
Jeroen P A Houwen1, Charlotte S Hakkers2, Valentijn A Schweitzer3
1Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, the Netherlands.
Background:
Implant-associated spinal infections (IASI) pose challenges for outpatient management due to the need for frequent intravenous antibiotic administration. Dalbavancin has a prolonged half-life and is a practical alternative.
Methods:
Two cases of IASI were treated with dalbavancin in an outpatient setting over 10-12 weeks. One patient received therapeutic drug monitoring (TDM)-guided dosing, while the other was managed with fixed-interval dosing. Dalbavancin plasma concentrations were measured using liquid chromatography-tandem mass spectrometry, and dosing adjustments were guided by pharmacokinetic modeling.
Results:
In the TDM-guided case, three dalbavancin doses were sufficient to maintain therapeutic plasma concentrations (≥8 mg/L), whereas the fixed-interval approach required four doses. Both patients successfully completed therapy without recurrence of the infection during follow-up.
Conclusions:
TDM-guided dalbavancin therapy optimized drug exposure and reduced the number of doses compared with fixed-interval dosing, highlighting its potential to optimize treatment. Further research is required to establish standardized therapeutic drug monitoring protocols for the management of IASI.
Related Concept Videos
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Dosage Interval and Administration Route: Determination Methods
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Affecting Factors

